Among these TFs, HIF1A induces the up‐regulation of PD‐L1 under hypoxic conditions and it could bind to the transcriptionally active hypoxia response element (HRE) in the PD‐L1 proximal promoter, which means that some TFs could play key role in tumor immunotherapy.46 Here, HIF1A is linked to neoplasm.